Point72 Asset Management, L.P. - 12 May 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
CTMX
Shares outstanding
157,763,855 shares
Disclosed Ownership
13,094,400 shares
Ownership
8.3%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 17:14:47 UTC
Date of event
12 May 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 8.3% ownership in CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX) on 12 May 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX).
  • Disclosed ownership: 8.3%.
  • Date of event: 12 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 17:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 8.3% 13,094,400 0 13,094,400 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 8.3% 13,094,400 0 13,094,400 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 8.3% 13,094,400 0 13,094,400 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person

Sponsored